Abstract
Introduction
There is a lack information regarding how sentinel lymph node biopsy (SLNB) for breast cancer is carried out today in developing countries and how it was adapted. To rectify this situation we performed a pattern-of-practice survey amongst practicing surgeons in Latin America (LA).
Methods
A survey was developed to assess current surgical practice in breast cancer, use of SLNB, limitations to the implementation, training, technique variations, and observed adverse events. A total of 30 surgical associations and breast surgery societies in 18 Latin American countries were invited to participate. Surveys were distributed among member of these associations and 76.7 % of those contacted answered the survey. Responses were limited only to those who reported treating breast cancer patients.
Results
A total of 463 surgeons who manage breast cancer responded. Over 53 % of surgeons do not have sub-specialty training. Only 47.7 % have a high-volume case load, of which 87.8 % routinely perform SLNB. The main limitations perceived to the implementation of SLNB were a lack of resources/equipment (48 %) and training opportunities (33 %). Over 60 % reported that fewer than half of their patients were eligible for SLNB and 67.8 % reported that they were involved in teaching this technique to residents.
Conclusions
A significant proportion of surgeons that treat breast cancer cases in LA have not had sub-specialty training or manage a low volume of cases. Among those surgeons with a high-volume caseload, SLNB is routinely performed. SLNB training during residency represents an opportunity for improvement in the region.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D, editors (2012) Globocan 2008: cancer incidence and mortality worldwide. IARC CancerBase No. 10
Parkin DM, Fernandez LM (2006) Use of statistics to assess the global burden of breast cancer. Breast J 12(Suppl 1):S70–S80
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C (2005) Trends in cancer mortality in the Americas, 1970–2000. Ann Oncol 16:489–511
Key TJ, Verkasalo PK, Banks E (2001) Epidemiology of breast cancer. Lancet Oncol 2:133–140
Schwartsmann G (2001) Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol 19:118S–124S
Lozano-Ascencio R, Gomez-Dantes H, Lewis S, Torres-Sanchez L, Lopez-Carrillo L (2009) Breast cancer trends in Latin America and the Caribbean. Salud Publica Mex 51(Suppl 2):s147–s156
Reyes-Ortiz CA, Freeman JL, Pelaez M, Markides KS, Goodwin JS (2006) Mammography use among older women of seven Latin American and Caribbean cities. Prev Med 42:375–380
Forouzanfar MH, Foreman KJ, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378:1461–1484
Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72–81
Baquet CR, Commiskey P (2000) Socioeconomic factors and breast carcinoma in multicultural women. Cancer 88:1256–1264
Robles SC, Galanis E (2002) Breast cancer in Latin America and the Caribbean. Rev Panam Salud Publica 11:178–185
Buccimazza I (2011) Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities. World J Surg 35:1155–1158. doi:10.1007/s00268-011-0956-3
Rescigno J, Zampell JC, Axelrod D (2009) Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol 16:687–696
Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398 (discussion 398–401)
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553
Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–339 (discussion 340)
Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 339:941–946
Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720
Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350
Bafford A, Gadd M, Gu X, Lipsitz S, Golshan M (2010) Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma. Am J Surg 200:374–377
Wilke LG, McCall LM, Posther KE et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491–500
Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599–609
McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213–5219
No authors listed (2009) Breast cancer in developing countries. Lancet 374:1567
McDermott AM, Wall DM, Waters PS et al (2013) Surgeon and breast unit volume–outcome relationships in breast cancer surgery and treatment. Ann Surg 258(5):808–813
Quan ML, Hodgson N, Lovrics P, Porter G, Poirier B, Wright FC (2008) National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience. Breast J 14:421–427
Carlson RW, Anderson BO, Chopra R et al (2003) Treatment of breast cancer in countries with limited resources. Breast J 9(Suppl 2):S67–S74
Olopade OI, Schwartsmann G, Saijo N, Thomas CR Jr (2006) Disparities in cancer care: a worldwide perspective and roadmap for change. J Clin Oncol 24:2135–2136
Vanderveen KA, Paterniti DA, Kravitz RL, Bold RJ (2007) Diffusion of surgical techniques in early stage breast cancer: variables related to adoption and implementation of sentinel lymph node biopsy. Ann Surg Oncol 14:1662–1669
Davis KG, Schriver JP (2002) Prevalence of teaching sentinel lymph node biopsy for breast cancer in general surgery residency programs. Curr Surg 59:420–422
Angarita FA, Acuna SA, Cervera S, Torregrosa L, Tawil M (2012) Meeting surgical necessities for sentinel lymph node biopsy in breast cancer: experience with methylene blue in a Colombian hospital. Breast J 18(6):618–619
Gallegos-Hernandez JF, Chavez-Garcia MA, Najera I, Ramirez-Ramirez L, Duran-Martinez M (2003) Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Gac Med Mex 139:205–208
Chintamani Tandon M, Mishra A, Agarwal U, Saxena S (2011) Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer–a prospective study. World J Surg Oncol 9:19
Golshan M, Nakhlis F (2006) Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 12:428–430
Varghese P, Mostafa A, Abdel-Rahman AT et al (2007) Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol 33:147–152
Krikanova M, Biggar M, Moss D, Poole G (2010) Accuracy of sentinel node biopsy for breast cancer using blue dye alone. Breast J 16:384–388
Clarke D, Newcombe RG, Mansel RE, ALMANAC Trialists Group (2004) The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 11:211S–215S
Sanidas EE, de Bree E, Tsiftsis DD (2003) How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 185:202–210
Quan ML, Wells BJ, McCready D, Wright FC, Fraser N, Gagliardi AR (2010) Beyond the false negative rate: development of quality indicators for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 17:579–591
Acuna SA, Angarita FA, McCready DR, Escallon J (2013) Quality indicators for sentinel lymph node biopsy: Is there room for improvement? Can J Surg 56:82–88
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575
Acknowledgments
This project was financed by The Marvelle Koffler Breast Centre, Mount Sinai Hospital, Toronto, Canada.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Acuna, S.A., Angarita, F.A. & Escallon, J. Assessing Patterns of Practice of Sentinel Lymph Node Biopsy for Breast Cancer in Latin America. World J Surg 38, 1077–1083 (2014). https://doi.org/10.1007/s00268-013-2382-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-013-2382-1